Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Gross Margin (2016 - 2026)

Biomerica's Gross Margin history spans 17 years, with the latest figure at 4.46% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 616.0% to 4.46% in Q1 2026 year-over-year; TTM through Feb 2026 was 4.32%, a 915.0% decrease, with the full-year FY2025 number at 9.38%, down 191.0% from a year prior.
  • Gross Margin hit 4.46% in Q1 2026 for Biomerica, down from 4.21% in the prior quarter.
  • Over the last five years, Gross Margin for BMRA hit a ceiling of 30.72% in Q3 2025 and a floor of 32.58% in Q2 2025.
  • Historically, Gross Margin has averaged 8.33% across 5 years, with a median of 10.8% in 2023.
  • Biggest five-year swings in Gross Margin: surged 2741bps in 2023 and later crashed -3437bps in 2025.
  • Tracing BMRA's Gross Margin over 5 years: stood at 23.75% in 2022, then dropped by -13bps to 20.74% in 2023, then increased by 29bps to 26.71% in 2024, then tumbled by -84bps to 4.21% in 2025, then crashed by -206bps to 4.46% in 2026.
  • Business Quant data shows Gross Margin for BMRA at 4.46% in Q1 2026, 4.21% in Q4 2025, and 30.72% in Q3 2025.